her2 breast cancer: neratinib patient selection
Published 6 years ago • 1.2K plays • Length 4:09Download video MP4
Download video MP3
Similar videos
-
4:54
patient selection for neratinib
-
2:18
use of neratinib in her2-positive breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:09
dr. dang on neratinib in patients with her2 breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
8:12
her2 breast cancer: neratinib’s role as adjuvant therapy
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
3:15
neratinib for metastatic breast cancer
-
1:08
dr. ali on choosing neratinib in her2 breast cancer
-
1:39
dr. anders discusses the use of neratinib/capecitabine for her2-positive brain metastases
-
1:41
dr. traina discusses neratinib in her2 breast cancer
-
1:14
dr. lin on cns-specific outcomes with neratinib in her2 breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
1:12
dr. nye on neratinib-associated diarrhea in her2 breast cancer
-
1:44
dr. blackwell on neratinib in her2 breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
2:34
eleanor: real-world use of neratinib in her2 , early breast cancer
-
5:24
the extenet trial